Cycloserine

Chemical nature and mechanism of action

Cycloserine is a unique antibacterial drug whose mechanism of action is based on molecular mimicry. Chemically, this substance is an exact structural analogue of D-alanine, a vital amino acid without which the formation of a complete bacterial cell wall is impossible.

Upon entering the body, the drug acts as an irreversible inhibitor. It binds tightly to key bacterial enzymes, completely blocking their function. The two main targets are:

1. Alanine racemase. Under normal conditions, this enzyme is responsible for the spatial rearrangement of the molecule, converting ordinary L-alanine into specific D-alanine. Cycloserine stops this process at the very first stage.
2. D-alanyl-D-alanine synthetase. If some amount of D-alanine manages to be synthesized, the second enzyme comes into play, whose task is to join two D-alanine molecules into a single dipeptide. Cycloserine blocks this reaction as well.

As a result of this dual irreversible inhibition, the bacterial cell is deprived of building material, the synthesis of its cell wall stops, which inevitably leads to the death of the microorganism.

Clinical application and the problem of resistance

In modern pharmacology, cycloserine occupies a strictly defined clinical niche — it is a second-line drug, or reserve drug. It is not used for routine therapy due to its safety profile.

The main indication for its use is multidrug-resistant tuberculosis (MDR-TB). In situations where mycobacteria cease to respond to standard drugs, cycloserine becomes a vital element of combination therapy. The second indication is urinary tract infections. This is directly related to the drug's pharmacokinetics: like fosfomycin, cycloserine is eliminated from the body via urinary excretion, creating high therapeutic concentrations in the urinary tract.

However, the use of the drug is seriously limited by the fact that resistance to it develops extremely rapidly. Bacteria employ two main defense mechanisms:

• Target overexpression. Microorganisms begin to synthesize alanine racemase in huge quantities. The enzyme molecules become so numerous that the drug is simply insufficient to block them completely.
• Mutations of transport systems. Since cycloserine mimics alanine, it enters the cell through the same transport channels responsible for the uptake of this amino acid. By mutating the alanine transport (uptake) system, the bacterium literally "closes the door" to the antibiotic.

Safety profile and drug interactions

The use of cycloserine requires a high degree of clinical vigilance due to its specific adverse effect profile. The drug exhibits pronounced neurotoxicity. Patients may develop severe complications, including seizures, acute psychosis, and painful peripheral neuropathy.

To minimize these risks, it is critically important to consider drug interactions:

• Increased toxicity. Combining therapy with alcohol is strictly prohibited. Furthermore, neurotoxicity is mutually enhanced when administered concurrently with other anti-tuberculosis drugs — isoniazid and ethionamide.
• Pharmacological protection. To mitigate side effects and protect nerve fibers, pyridoxine (vitamin B6) is mandatory in the treatment regimen. Its administration reliably reduces the manifestations of peripheral neuropathy.
• Effect on the metabolism of other drugs. Cycloserine can interfere with hepatic enzyme systems. Specifically, it inhibits the hepatic metabolism of phenytoin, which requires monitoring when co-administered.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Structural similarity of cycloserine and D-alanine: molecular basis
• Mechanism of irreversible inhibition of cell wall enzymes
• Pharmacokinetics: features of urinary excretion
• Neurotoxicity: pathogenesis of seizures and psychosis
• Interaction of cycloserine with the hepatic metabolism of phenytoin

Other topics in the section "Antibacterial Chemotherapeutic Agents"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.